This site is intended only for healthcare professionals resident in the United Kingdom

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Click here for Inflectra® (infliximab) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.

PROSIT-BIO SAE Summary

Safety

The primary endpoint was the the evaluation of safety in terms of rate of SAEs during the first year since the introduction of Inflectra/CT-P13* (infliximab) for the overall population.

Breakdown of SAEs experienced by the overall population.1

Adapted from Fliorino G. et al. 2017.

Explore more

Crohn’s disease safety

Learn about the safety profile of Inflectra in patients with Crohn’s disease

Learn more

Crohn’s disease dosing

Learn about the dosing and administration of Inflectra in patients with Crohn’s disease

Find out more
*CT-P13 is marketed under different brand names including Inflectra and REMSIMA®.
SAE=Serious adverse event
References
  1. Fiorino G, et al. Inflamm Bowel Dis 2017. 23:233–243.
PP-IFA-GBR-0417. March 2021

Quick Links

  • GONCZI L et al

  • Study 3.4

  • NOR-SWITCH safety

  • NOR-SWITCH efficacy

  • PROSIT-BIO safety

  • PROSIT-BIO efficacy

  • PROSIT-BIO study design

  • Switch studies

  • Paediatric studies

  • Induction & Maintenance

  • Inflammatory bowel disease

Learn about the evidence supporting the use of Inflectra in patients with rheumatoid arthritis. 

Find out more

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-2688. December 2020

Yes

No